ad

IFCI Q1 Results FY26: Q1 PAT Soars 136.92% to ₹39.95 Crore; Revenue Up 5.00% YoY

Q1 Results FY26


11 Aug 20253:43 pm

IFCI Q1 Results FY26: Q1 PAT Soars 136.92% to ₹39.95 Crore; Revenue Up 5.00% YoY

IFCI Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

ParticularsQuarter Ended
30-06-202530-06-2024
Revenue from Operations₹407.18₹387.80
Profit Before Tax (PBT)₹230.28₹194.99
Profit After Tax (PAT)₹39.95-₹108.20

(Figures in crores)

IFCI Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

ParticularsQuarter Ended
30-06-202530-06-2024
Revenue from Operations₹155.51₹122.38
Profit Before Tax (PBT)₹138.59₹104.22
Profit After Tax (PAT)₹7.38-₹148.24

(Figures in crores)

IFCI Q1 Results FY26 Highlights (Q1 FY26 vs FY25)

  • IFCI clocked Q1 FY26 consolidated revenue of ₹407.18 crores vs ₹387.80 crores. 
  • On the profit front, IFCI earned a consolidated PAT of ₹39.95 crore in Q1 FY26. During FY25, the company’s PAT stood at -₹108.20 crore. 
  • Consolidated PAT rose for the first quarter of FY26, was 136.92% YoY, and revenue rose 5.00% YoY. 
  • As per the standalone figures, the quarterly PAT of IFCI has increased by 104.98%, and revenue has increased by 27.07% YoY.

IFCI Share Price Performance

On the opening bell of 11th August 2025, the shares of IFCI opened at ₹53.01 per share. However, the initial gains are wiped out as of now, and IFCI shares are trading at ₹52.40 per share, higher than their opening price. 

Considering the long-term performance, IFCI shares have yielded close to -29.36% returns in the past 1 year, and 5-year returns stand at 638.31%. Over the maximum timeframe, the IFCI share provided 211.34% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in IFCI shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Also Read : Glenmark Life Sciences Q1 Results FY26: Q1 PAT Rises 9.02% to ₹121.54 Crore; Revenue Surged 2.25% YoY

Recent Articles

Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates

Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates

Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?

Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY

Action Construction Equipment Q1 Results FY26: Q1 PAT Rises 16.08% to ₹97.72 Crore; Revenue Down 11.19% YoY

Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More

JSW Cement IPO Allotment Status Check Online: GMP, Subscription, Price, and More

Mahendra Realtors IPO GMP & Review: Apply or Avoid?

Regaal Resources IPO GMP & Review: Apply or Avoid?

Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
Google for Startups Accelerator 2024
Trusted by 70 lakh+ Indians
Awarded No. 1 by Economic times